Vorasidenib
NCT06478212
Servier · Phase 1/2 · Active, not recruiting · Enrollment 51
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
Vorasidenib
Servier · Phase 1/2 · Active, not recruiting · Enrollment 51
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.